Perceptive Advisors Has Decreased Ani Pharmaceuticals (ANIP) Holding; Johnson Controls (JCI) Sellers Increased By 21.48% Their Shorts

September 30, 2017 - By Darrin Black

Johnson Controls Incorporated (NYSE:JCI) had an increase of 21.48% in short interest. JCI’s SI was 29.29M shares in September as released by FINRA. Its up 21.48% from 24.11M shares previously. With 6.52M avg volume, 5 days are for Johnson Controls Incorporated (NYSE:JCI)’s short sellers to cover JCI’s short positions. The stock increased 0.55% or $0.22 on September 29, reaching $40.29. About 3.90 million shares traded. Johnson Controls International plc Ordinary Share (NYSE:JCI) has risen 13.24% since September 30, 2016 and is uptrending. It has underperformed by 3.46% the S&P500.

Perceptive Advisors Llc decreased Ani Pharmaceuticals Inc (ANIP) stake by 50.8% reported in 2017Q2 SEC filing. Perceptive Advisors Llc sold 129,490 shares as Ani Pharmaceuticals Inc (ANIP)’s stock declined 26.94%. The Perceptive Advisors Llc holds 125,399 shares with $5.87M value, down from 254,889 last quarter. Ani Pharmaceuticals Inc now has $610.90M valuation. The stock increased 1.82% or $0.94 on September 29, reaching $52.49. About 90,187 shares traded. ANI Pharmaceuticals Inc (NASDAQ:ANIP) has declined 0.02% since September 30, 2016 and is downtrending. It has underperformed by 16.72% the S&P500.

Among 24 analysts covering Johnson Controls Inc. (NYSE:JCI), 16 have Buy rating, 0 Sell and 8 Hold. Therefore 67% are positive. Johnson Controls Inc. had 61 analyst reports since July 28, 2015 according to SRatingsIntel. RBC Capital Markets maintained Johnson Controls International plc Ordinary Share (NYSE:JCI) rating on Monday, July 10. RBC Capital Markets has “Hold” rating and $4800 target. The firm earned “Sector Perform” rating on Tuesday, November 1 by RBC Capital Markets. William Blair upgraded the stock to “Outperform” rating in Wednesday, September 30 report. The rating was downgraded by Gabelli to “Hold” on Tuesday, December 6. As per Monday, November 28, the company rating was initiated by Citigroup. The company was initiated on Monday, October 24 by Goldman Sachs. The firm has “Buy” rating given on Friday, April 28 by Cowen & Co. The rating was downgraded by RBC Capital Markets to “Sector Perform” on Tuesday, December 15. Barclays Capital reinitiated it with “Equal Weight” rating and $48 target in Friday, December 9 report. The firm earned “Market Perform” rating on Wednesday, December 2 by William Blair.

Investors sentiment decreased to 0.5 in Q2 2017. Its down 0.25, from 0.75 in 2017Q1. It is negative, as 9 investors sold Johnson Controls International plc Ordinary Share shares while 5 reduced holdings. 1 funds opened positions while 6 raised stakes. 1.80 million shares or 18.07% less from 2.20 million shares in 2017Q1 were reported. Altfest L J Inc holds 6,252 shares. Cutler Limited Liability Com holds 18,000 shares or 0.38% of its portfolio. Amer Rech Mngmt has invested 0.01% in Johnson Controls International plc Ordinary Share (NYSE:JCI). Covington Mgmt holds 0.31% of its portfolio in Johnson Controls International plc Ordinary Share (NYSE:JCI) for 88,254 shares. Prentiss Smith & Comm Incorporated reported 0% in Johnson Controls International plc Ordinary Share (NYSE:JCI). Schwartz Investment Counsel Inc reported 676,053 shares or 1.88% of all its holdings. Cullinan Incorporated reported 131,900 shares or 0.45% of all its holdings. Axiom Ltd Liability Company De has 0.73% invested in Johnson Controls International plc Ordinary Share (NYSE:JCI). Vantage Inv Limited Liability Company holds 0.01% of its portfolio in Johnson Controls International plc Ordinary Share (NYSE:JCI) for 1,141 shares. Cleararc owns 0.17% invested in Johnson Controls International plc Ordinary Share (NYSE:JCI) for 23,855 shares. Aspen Inv Inc reported 0.36% of its portfolio in Johnson Controls International plc Ordinary Share (NYSE:JCI). Alphamark Advsrs Limited Liability Company accumulated 95 shares. Marquette Asset Mngmt owns 0.1% invested in Johnson Controls International plc Ordinary Share (NYSE:JCI) for 5,283 shares. 3,797 are owned by Farmers Savings Bank. Gemmer Asset Limited Com stated it has 0.01% of its portfolio in Johnson Controls International plc Ordinary Share (NYSE:JCI).

Investors sentiment decreased to 1.06 in 2017 Q2. Its down 0.34, from 1.4 in 2017Q1. It is negative, as 20 investors sold ANIP shares while 42 reduced holdings. 17 funds opened positions while 49 raised stakes. 6.39 million shares or 4.42% more from 6.12 million shares in 2017Q1 were reported. Northern Corp owns 112,905 shares. Pnc Service Gru accumulated 71,160 shares. Pacad holds 1,900 shares. Thrivent Fincl For Lutherans holds 4,840 shares. Shine Advisory owns 25 shares. Riverhead Llc invested in 898 shares or 0% of the stock. Stevens Capital LP invested in 4,417 shares. Deutsche National Bank Ag owns 169,780 shares or 0.01% of their US portfolio. Cwm Lc invested 0% in ANI Pharmaceuticals Inc (NASDAQ:ANIP). Dana Inc owns 42,720 shares or 0.09% of their US portfolio. Envestnet Asset Management, a Illinois-based fund reported 3,337 shares. Mason Street Advsrs Ltd Limited Liability Company holds 0% or 1,980 shares. Ls Inv Advsr Ltd holds 0% of its portfolio in ANI Pharmaceuticals Inc (NASDAQ:ANIP) for 1,741 shares. Credit Suisse Ag owns 5,734 shares or 0% of their US portfolio. Swiss Fincl Bank reported 0% of its portfolio in ANI Pharmaceuticals Inc (NASDAQ:ANIP).

Among 6 analysts covering ANI Pharma (NASDAQ:ANIP), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. ANI Pharma had 16 analyst reports since July 31, 2015 according to SRatingsIntel. As per Thursday, June 23, the company rating was initiated by Raymond James. As per Wednesday, February 22, the company rating was downgraded by TH Capital. TH Capital maintained the stock with “Neutral” rating in Tuesday, August 4 report. Oppenheimer upgraded the shares of ANIP in report on Tuesday, July 19 to “Perform” rating. The stock of ANI Pharmaceuticals Inc (NASDAQ:ANIP) has “Hold” rating given on Tuesday, May 24 by Standpoint Research. The firm has “Outperform” rating by Oppenheimer given on Friday, August 5. The firm has “Buy” rating by Roth Capital given on Monday, September 28. As per Wednesday, September 2, the company rating was downgraded by TheStreet. The firm has “Outperform” rating by Oppenheimer given on Friday, July 31. Standpoint Research initiated the shares of ANIP in report on Friday, November 13 with “Buy” rating.

Perceptive Advisors Llc increased Axovant Sciences Ltd stake by 372,700 shares to 572,700 valued at $13.28M in 2017Q2. It also upped Bluebird Bio Inc (NASDAQ:BLUE) stake by 15,356 shares and now owns 20,000 shares. Invitae Corp was raised too.